<http://www.sciencedaily.com/releases/2007/12/071205190850.htm>:

----- Begin Quote -----

A significant number of HIV-infected individuals who receive antiviral
therapy develop lipodystrophy. Symptoms of the syndrome include a loss
of subcutaneous fat in the face, arms, and legs and increased fat
deposits in the abdomen. The metabolic aspects of the syndrome --
changes in cholesterol and other blood lipids, and development of
insulin resistance -- could increase the risk of cardiovascular
disease in HIV-infected patients.

Earlier studies found that growth hormone secretion is reduced in men
with lipodystrophy. Since directly injecting growth hormone can have
significant side effects, researchers at the MGH previously
investigated the use of growth-hormone-releasing hormone (GHRH) to
increase levels in a way that mimics natural control of hormone
levels.

----- End Quote -----

Hmmm, nice.

"Symptoms of the syndrome include a loss of subcutaneous fat in the
face, arms, and legs..."

That sounds like a drug induced 'AIDS look.'